RedHill Biopharma

(NASDAQ) RDHL

Current Price$1.09

Market Cap$5.53M

Since IPO (2013)-100%

5 Year-100%

1 Year-50%

1 Month+33%

RedHill Biopharma Financials at a Glance

Market Cap

$5.53M

Revenue (TTM)

$9.55M

Net Income (TTM)

$9.31M

EPS (TTM)

$0.00

P/E Ratio

-0.01

Dividend

$0.00

Beta (Volatility)

1.26 (Average)

Dividend

$0.00

Beta (Volatility)

1.26 (Average)

Price

$1.09

Volume

41,287.211

Open

$1.09

Price

$1.09

Volume

41,287.211

Open

$1.09

Previous Close

$1.04

Daily Range

$1.04 - $1.09

52-Week Range

$0.71 - $3.31

Dividend

$0.00

Beta (Volatility)

1.26 (Average)

Price

$1.09

Volume

41,287.211

Open

$1.09

Previous Close

$1.04

Daily Range

$1.04 - $1.09

52-Week Range

$0.71 - $3.31

RDHL News

A medical professional using a microscope

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About RedHill Biopharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Dror Ben-Asher

Website

www.redhillbio.com

Headquarters

Tel Aviv, 6473921, IL

RDHL Financials

Key Financial Metrics (TTM)

Gross Margin

63%

Operating Margin

-1%

Net Income Margin

-99%

Return on Equity

Return on Capital

-1%

Return on Assets

-27%

Earnings Yield

-100.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.53M

Shares Outstanding

5.09M

Volume

41.29K

Avg. Volume

38.99K

Financials (TTM)

Gross Profit

$286.00K

Operating Income

$7.91M

EBITDA

$7.65M

Operating Cash Flow

$9.65M

Capital Expenditure

$5.00K

Free Cash Flow

$9.66M

Cash & ST Invst.

$3.97M

Total Debt

$1.07M

RedHill Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$2.04M

+58.6%

Gross Profit

$1.24M

+111.6%

Gross Margin

60.60%

N/A

Market Cap

$5.53M

N/A

Market Cap/Employee

$157.86K

N/A

Employees

N/A

Net Income

$2.07M

-33.8%

EBITDA

$2.10M

+47.6%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Net Cash

$2.90M

-31.9%

Accounts Receivable

$2.48M

-2.4%

Inventory

$0.00

-100.0%

Long Term Debt

$900.00K

+29900.0%

Short Term Debt

$170.00K

-51.8%

Return on Assets

-26.53%

N/A

Return on Invested Capital

-1.22%

N/A

Free Cash Flow

$2.51M

+18.9%

Operating Cash Flow

$2.51M

+18.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCNS Pharmaceuticals, Inc.

CNSPCNS Pharmaceuticals, Inc.$7.84+239.39%

FLGCFlora Growth Corp.

FLGCFlora Growth Corp.$7.79-32.14%

BGMSBio Green Med Solution, Inc.

BGMSBio Green Med Solution, Inc.$1.03+5.10%

AKANAkanda Corp.

AKANAkanda Corp.$41.08-28.04%

SXTP60 Degrees Pharmaceuticals, Inc.

SXTP60 Degrees Pharmaceuticals, Inc.$1.61-3.01%

IMCCIM Cannabis Corp.

IMCCIM Cannabis Corp.$0.28-1.72%

BNBXBNB Plus Corp.

BNBXBNB Plus Corp.$0.50+0.75%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.14-0.01%

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.84+2.39%

GBTGGlobal Business Travel Group

GBTGGlobal Business Travel Group$9.34+0.58%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.18+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.69-0.00%

SOFISoFi Technologies

SOFISoFi Technologies$16.20-0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.40+0.02%

Questions About RDHL

What is the current price of RedHill Biopharma?

RedHill Biopharma is trading at $1.04 per share.

What is the 52-week range for RedHill Biopharma?

Over the past 52 weeks, RedHill Biopharma has traded between $0.71 and $3.31.

How much debt does RedHill Biopharma have?

As of the most recent reporting period, RedHill Biopharma reported total debt of $1.07M.

How much cash does RedHill Biopharma have on hand?

RedHill Biopharma reported $3.97M in cash and cash equivalents in its most recent financial results.

What is RedHill Biopharma’s dividend yield?

RedHill Biopharma does not currently have a dividend yield.

RedHill Biopharma

RedHill Biopharma Financials at a Glance

RDHL News

Why RedHill Biopharma Blasted 12% Higher Today

Why RedHill Biopharma Stock Is Getting Crushed Today

Why RedHill Biopharma Stock Jumped on Tuesday

Why RedHill Biopharma Stock Is Tanking Today

Why RedHill Biopharma Is Trouncing the Market Today

Here's Why RedHill Biopharma Jumped on Monday

3 Biotech Stocks That Could Double Your Money

Why Redhill Biopharma Ltd. Stock Is Soaring Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About RedHill Biopharma

RDHL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

RedHill Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RDHL

What is the current price of RedHill Biopharma?

What is the 52-week range for RedHill Biopharma?

How much debt does RedHill Biopharma have?

How much cash does RedHill Biopharma have on hand?

What is RedHill Biopharma’s dividend yield?

Premium Investing Services